Screener
Grace Therapeutics, Inc. GRCE Q3 2026 earnings
Reported November 12, 2026 · Before market open
EPS-$0.11Beat by $0.04
Revenue estimate$1.0M
EPS estimate-$0.15
Next report
Feb 15, 2027 (in 3 months)Revenue estimate$2.3M
EPS estimate-$0.15
Versus estimates
Diluted EPS
FAQ
- When did Grace Therapeutics, Inc. report Q3 2026 earnings?
- Grace Therapeutics, Inc. (GRCE) reported Q3 2026 earnings on November 12, 2026 before market open.
- What were Grace Therapeutics, Inc.'s Q3 2026 revenue and EPS?
- Grace Therapeutics, Inc. reported eps of $-0.11 for Q3 2026.
- Did Grace Therapeutics, Inc. beat estimates in Q3 2026?
- EPS beat the consensus estimate of $-0.15 by $0.04.
- How did Grace Therapeutics, Inc.'s Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 26.7% from $-0.15.
- Where can I find Grace Therapeutics, Inc.'s Q3 2026 SEC filings?
- You can read the 8-K earnings release (0001140361-26-043308) and the 10-Q periodic report (0001140361-26-043299) directly on SEC EDGAR. The filing index links above go to sec.gov.
